(S)-2-((S)-2-((S)-1-((6S,9S,12S,15S)-1-amino-9,15-dibenzyl-22-hexadecyl-1-imino-12-isobutyl-18,18-dimethyl-8,11,14,17,20,24-hexaoxo-2,7,10,13,16,19,22,25-octaazahentetracontanecarbonyl)pyrrolidine-2-carboxamido)-5-guanidinopentanamido)succinamide

ID: ALA3758845

Chembl Id: CHEMBL3758845

PubChem CID: 127027325

Max Phase: Preclinical

Molecular Formula: C85H146N18O11

Molecular Weight: 1596.22

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCCCCCNC(=O)CN(CCCCCCCCCCCCCCCC)CC(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O

Standard InChI:  InChI=1S/C85H146N18O11/c1-7-9-11-13-15-17-19-21-23-25-27-29-31-39-51-92-73(105)60-102(54-40-32-30-28-26-24-22-20-18-16-14-12-10-8-2)61-74(106)101-85(5,6)82(114)100-70(58-64-46-37-34-38-47-64)79(111)98-68(56-62(3)4)77(109)99-69(57-63-44-35-33-36-45-63)78(110)96-66(49-42-53-94-84(90)91)81(113)103-55-43-50-71(103)80(112)95-65(48-41-52-93-83(88)89)76(108)97-67(75(87)107)59-72(86)104/h33-38,44-47,62,65-71H,7-32,39-43,48-61H2,1-6H3,(H2,86,104)(H2,87,107)(H,92,105)(H,95,112)(H,96,110)(H,97,108)(H,98,111)(H,99,109)(H,100,114)(H,101,106)(H4,88,89,93)(H4,90,91,94)/t65-,66-,67-,68-,69-,70-,71-/m0/s1

Standard InChI Key:  JQNXGWPBDJPKJI-WGSYXVSUSA-N

Alternative Forms

  1. Parent:

    ALA3758845

    ---

Associated Targets(Human)

NMUR1 Tchem Neuromedin-U receptor 1 (374 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NMUR2 Tchem Neuromedin-U receptor 2 (383 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1596.22Molecular Weight (Monoisotopic): 1595.1418AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Micewicz ED, Bahattab OS, Willars GB, Waring AJ, Navab M, Whitelegge JP, McBride WH, Ruchala P..  (2015)  Small lipidated anti-obesity compounds derived from neuromedin U.,  101  [PMID:26204509] [10.1016/j.ejmech.2015.07.020]

Source